Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 44

Sort by

Sort Order Select

Journal Articles

Home Treatment of Bortezomib: A Preliminary Exploration of a New Treatment Mode in China

Congli Zhang, Xin-xin Cao, Dong-zhu Li, Jun Feng, MD, Lu Zhang, MD, Yan Zhang, Ming-hui Duan, MD, Miao Chen, MD, Chen Yang, Wei Wang, Dao-Bin Zhou, Jian Li, MD

Blood (2019) 134 (Supplement_1): 2127.

https://doi.org/10.1182/blood-2019-125505

Published: 2019

Journal Articles

The Utilization of Screening Tests for Plasma Cell Dyscrasias By Internal Medicine Physicians at a Teaching Hospital

Omar Abughanimeh, MD, Ahmad Al-Shyoukh, Anahat Kaur, MD, Diala Alawneh, Soheila Hamidpour, Anuj Shrestha, MD, Sheshadri Madhusudhana, MD

Blood (2019) 134 (Supplement_1): 4732.

https://doi.org/10.1182/blood-2019-123077

Published: 2019

Journal Articles

Proteomic evidence of specific IGKV1-8 association with cystic lung light chain deposition disease

Mylène Camus, Sandrine Hirschi, Grégoire Prevot, Marie-Pierre Chenard, Hervé Mal, Marc Stern, Martine Reynaud-Gaubert, Julia Gilhodes, Odile Burlet-Schiltz, Pierre Brousset, Magali Colombat

Blood (2019) 133 (26): 2741–2744.

https://doi.org/10.1182/blood.2019898577

Published: 2019

Includes: Supplemental data

Journal Articles

Randall-type monoclonal immunoglobulin deposition disease: novel insights from a nationwide cohort study

Florent Joly, Camille Cohen, Vincent Javaugue, Sébastien Bender, Mohamed Belmouaz, Bertrand Arnulf, Bertrand Knebelmann, Mathilde Nouvier, Vincent Audard, François Provot, Viviane Gnemmi, Dominique Nochy, Jean Michel Goujon, Arnaud Jaccard, Guy Touchard, Jean Paul Fermand, Christophe Sirac, Frank Bridoux

Blood (2019) 133 (6): 576–587.

https://doi.org/10.1182/blood-2018-09-872028

Published: 2019

Includes: Supplemental data

Journal Articles

Monoclonal Gammopathy of Clinical Significance - a Single Center Experience

Holly Lee, MD, Lesley Street, MD, Jason Tay, MD, Jennifer Grossman, MD, John F Thaell, MD, Dawn Goodyear, MD, Sylvia McCulloch, MD, Peter Duggan, MD, Paola Neri, MD, Victor Jimenez-Zepeda, MD

Blood (2018) 132 (Supplement 1): 4495.

https://doi.org/10.1182/blood-2018-99-117819

Published: 2018

Journal Articles

Consolidation with a Short Course of Daratumumab Improves Complete Response Rates in Patients with AL Amyloidosis or Lcdd

Blood (2018) 132 (Supplement 1): 3246.

https://doi.org/10.1182/blood-2018-99-112764

Published: 2018

Journal Articles

Epidemiological and Clinical Characteristics of Monoclonal Gammopathy of Renal Significance (MGRS) in South America

Camila Peña, MD, Gonzalo P Mendez, MD, Natalia Paola Schutz, MD, Eloisa Riva, MD, Ricardo Valjalo, MD, Hernán López-Vidal, MD, Alejandro Majlis, MD, Vivianne Lois, MD, Daniela Zamora, MD, Jose T Gonzalez, MD, Dorotea Beatriz Fantl, MD

Blood (2018) 132 (Supplement 1): 5856.

https://doi.org/10.1182/blood-2018-99-113198

Published: 2018

Journal Articles

Identifying a Murine Xenograft Model Relevant to Light-Chain Specific Approaches to Human Ig Light-Chain Diseases

Adin Kugelmass, BSc, Ping Zhou, MD PhD, Xun Ma, DMD, MSc, PhD, Denis Toskic, Amandeep Godara, MD, Melissa Warner, BS, Lisa Xingguang Lee, MD, Teresa Fogaren, NP, Cindy Varga, MD BSc, Raymond L Comenzo, MD

Blood (2018) 132 (Supplement 1): 5611.

https://doi.org/10.1182/blood-2018-99-119381

Published: 2018

Journal Articles

Hematologic Responses in Patients with Heavily Pretreated Light Chain Deposition Disease (LCDD) Receiving Daratumumab

Paolo Milani, MD, Marco Basset, MD, Andrea Foli, MD, Giampaolo Merlini, MD, Giovanni Palladini, MDPhD

Blood (2018) 132 (Supplement 1): 1985.

https://doi.org/10.1182/blood-2018-99-118108

Published: 2018

Journal Articles

When it rains, it pours

Michaël Degaud, Pierre Sujobert

Blood (2018) 131 (7): 836.

https://doi.org/10.1182/blood-2017-10-814087

Published: 2018

Journal Articles

Phase I Trial of Pomalidomide, Bortezomib, and Dexamethasone As Frontline Treatment of AL Amyloidosis

Jeffrey A Zonder, MD, Vaishali Sanchorawala, MD, Vishal Kukreti, MD FRCP(C), Sascha A Tuchman, MD, Yubin Kang, MD, Divaya Bhutani, MD, Steven Burt, ANP, Christiane Houde, BS, Kathy A. Reichel, Silva Pregja, MBA, Jeffrey V Matous, MD

Blood (2017) 130 (Supplement 1): 3158.

https://doi.org/10.1182/blood.V130.Suppl_1.3158.3158

Published: 2017

Journal Articles

Characteristics of Light Chain Deposition Disease (LCDD) and Factors Affecting Outcome after Treatment

Jameel Muzaffar, MD, Abdullah Mohammad Khan, MBBS,MSc, Athira Unnikrishnan, MD, Preeti Narayan, MD, Dara Wakefield, MD, Jan S Moreb, MD

Blood (2017) 130 (Supplement 1): 5513.

https://doi.org/10.1182/blood.V130.Suppl_1.5513.5513

Published: 2017

Journal Articles

N-Terminal Fragment of the Type-B Natriuretic Peptide (NT-proBNP) Is an Independent Prognostic Factor for Overall Survival in Patients with Monoclonal Gammopathy of Undetermined Significance (MGUS)

Paolo Milani, MD, Morie A. Gertz, MD, Giampaolo Merlini, MD, Giovanni Palladini, MDPhD, Martha Q Lacy, MD, Francis K Buadi, MD, Shaji K Kumar, MD, Suzanne R. Hayman, MD, Nelson Leung, MD, David Dingli, MD, John A. Lust, MD PhD, Yi Lin, MD PhD, Prashant Kapoor, MD, Ronald S. Go, MD, Yi L. Hwa, DNP, Steven Zeldenrust, MD, Robert A Kyle, MD, S. Vincent Rajkumar, MD, Angela Dispenzieri, MD

Blood (2017) 130 (Supplement 1): 4349.

https://doi.org/10.1182/blood.V130.Suppl_1.4349.4349

Published: 2017

Journal Articles

Evolution of Monoclonal Gammopathy of Undetermined Significance in Kidney Transplant Recipients at the CHUM (Centre Hospitalier de l'Université de Montréal) — a Single-Institution Retrospective Study

Marie-France Gagnon, MD, Héloïse Cardinal, MDPhD, Jean-Pierre Emond, PhD, Bernard Lemieux, MD

Blood (2017) 130 (Supplement 1): 4366.

https://doi.org/10.1182/blood.V130.Suppl_1.4366.4366

Published: 2017

Journal Articles

Long Term Outcomes in Monoclonal Gammopathy of Renal Significance (MGRS)

Akhil Khera, Katja Kimberger, Fotios Panitsas, Chris Winearls, John Quinn, Simon Stern, Neil Rabin, Bassam Alchi, Ian Roberts, Richard Haynes, Karthik Ramasamy

Blood (2016) 128 (22): 5948.

https://doi.org/10.1182/blood.V128.22.5948.5948

Published: 2016

Journal Articles

Enlightening light chain deposition disease

Giampaolo Merlini, Giovanni Palladini

Blood (2015) 126 (26): 2770–2771.

https://doi.org/10.1182/blood-2015-10-672626

Published: 2015

Journal Articles

Natural history and outcome of light chain deposition disease

Rabya H. Sayed, Ashutosh D. Wechalekar, Janet A. Gilbertson, Paul Bass, Shameem Mahmood, Sajitha Sachchithanantham, Marianna Fontana, Ketna Patel, Carol J. Whelan, Helen J. Lachmann, Philip N. Hawkins, Julian D. Gillmore

Blood (2015) 126 (26): 2805–2810.

https://doi.org/10.1182/blood-2015-07-658872

Published: 2015

Includes: Supplemental data

Journal Articles

Light chain deposition disease

Blood (2015) 126 (26): 2902.

https://doi.org/10.1182/blood-2015-10-678334

Published: 2015

Journal Articles

Defining the Incidence, Pathology and Clinical Outcomes of Kidney Disease Related to Waldenstrom's Macroglobulinemia and IgM MGUS

Josephine M. Vos, MD, Robert R Manning, Kirsten Meid, MPH, Joshua Gustine, MPH, Christopher J Patterson, MFA, Philip Brodsky, Sandra Kanan, NP, RN, MSN, Marie José Kersten, MD PhD, Steven P Treon, MD PhD, Jorge J Castillo, MD

Blood (2015) 126 (23): 3926.

https://doi.org/10.1182/blood.V126.23.3926.3926

Published: 2015

Journal Articles

siRNA for the Ig Light Chain Constant Region Reduces Light Chain Production and Secretion By Human Plasma Cells and in a Murine Xenograft Model

Xun Ma, DDS, PhD, Ping Zhou, MD PhD, Monika Pilichowska, MD, Chakra P Chaulagain, MD FACP, Sandy Wong, MD, Raymond L. Comenzo, MD

Blood (2014) 124 (21): 5722.

https://doi.org/10.1182/blood.V124.21.5722.5722

Published: 2014

NARROW

Home Treatment of Bortezomib: A Preliminary Exploration of a New Treatment Mode in China

The Utilization of Screening Tests for Plasma Cell Dyscrasias By Internal Medicine Physicians at a Teaching Hospital

Proteomic evidence of specific IGKV1-8 association with cystic lung light chain deposition disease

Randall-type monoclonal immunoglobulin deposition disease: novel insights from a nationwide cohort study

Monoclonal Gammopathy of Clinical Significance - a Single Center Experience

Consolidation with a Short Course of Daratumumab Improves Complete Response Rates in Patients with AL Amyloidosis or Lcdd

Epidemiological and Clinical Characteristics of Monoclonal Gammopathy of Renal Significance (MGRS) in South America

Identifying a Murine Xenograft Model Relevant to Light-Chain Specific Approaches to Human Ig Light-Chain Diseases

Hematologic Responses in Patients with Heavily Pretreated Light Chain Deposition Disease (LCDD) Receiving Daratumumab

When it rains, it pours

Phase I Trial of Pomalidomide, Bortezomib, and Dexamethasone As Frontline Treatment of AL Amyloidosis

Characteristics of Light Chain Deposition Disease (LCDD) and Factors Affecting Outcome after Treatment

N-Terminal Fragment of the Type-B Natriuretic Peptide (NT-proBNP) Is an Independent Prognostic Factor for Overall Survival in Patients with Monoclonal Gammopathy of Undetermined Significance (MGUS)

Evolution of Monoclonal Gammopathy of Undetermined Significance in Kidney Transplant Recipients at the CHUM (Centre Hospitalier de l'Université de Montréal) — a Single-Institution Retrospective Study

Long Term Outcomes in Monoclonal Gammopathy of Renal Significance (MGRS)

Enlightening light chain deposition disease

Natural history and outcome of light chain deposition disease

Light chain deposition disease

Defining the Incidence, Pathology and Clinical Outcomes of Kidney Disease Related to Waldenstrom's Macroglobulinemia and IgM MGUS

siRNA for the Ig Light Chain Constant Region Reduces Light Chain Production and Secretion By Human Plasma Cells and in a Murine Xenograft Model

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only